Company / Income Tax
Mirum Pharmaceuticals, Inc. Income Tax History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$1.9M
FY2025
5-year range
$6.0K / $1.9M
FY2021-FY2025
Trend
+88.0%
vs FY2024
Sector context
#65 of 204
Health Care
What the data says
At $2M, Mirum Pharmaceuticals, Inc.'s income tax ranks #140 of 204 in the Health Care sector. Income Tax has increased for 4 consecutive years, from $6,000 in FY2021 to $2M in FY2025.
Based on SEC 10-K filings.
$2M in FY2025 with a 5-year CAGR of +217.5%.
Increased from $991,000 to $2M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- +274.0%
- 5-Year CAGR
- +217.5%
- 10-Year CAGR
- -
Sector benchmark
#140 of 204 in Health CareTop 68% of 204This company $1.9M Sector average $118.7M
▼
-98.4% below sector average
Key checks
Key Insights
- Mirum Pharmaceuticals, Inc.'s income tax has grown for 4 consecutive years.
- 5-year CAGR of +217.5%, indicating consistent growth.
- In FY2025, income tax increased 88.0% year-over-year.
- Ranks #65 out of 204 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -26.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.9M | +88.0% |
| FY2024 | $1.0M | +3.9% |
| FY2023 | $991.0K | +2578.4% |
| FY2022 | $37.0K | +516.7% |
| FY2021 | $6.0K | +0.0% |
| FY2020 | $6.0K | -71.4% |
| FY2019 | $21.0K | - |
| FY2018 | $0 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026